Literature DB >> 10688114

Iodinated free fatty acid and 201T1 uptake in chronically hypoperfused myocardium: histologic correlation study.

T Kudoh1, E Tadamura, N Tamaki, N Hattori, M Inubushi, S Kubo, Y Magata, K Nishimura, K Matsuda, J Konishi.   

Abstract

UNLABELLED: 123I-15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid (BMIPP) is a tracer for the evaluation of ischemic heart disease. The purpose of this study was to assess the relationship between 1231-BMIPP uptake and myocardial fibrosis.
METHODS: Fifteen patients who underwent cardiac surgery were examined by imaging with 201TI and 123I-BMIPP, and histologic specimens were taken during surgery. The relative uptake of 201TI (%TI) and that of 123I-BMIPP (%BMIPP) were calculated. The percentage of fibrosis (%fibrosis) was analyzed with the specimen.
RESULTS: %TI correlated strongly with %fibrosis (r = -0.94; P < 0.001). %BMIPP also correlated significantly with %fibrosis (r = -0.88; P < 0.001), but the change in %BMIPP looked biphasic. In the category of only mild fibrosis, %BMIPP showed a steep decrease. 123I-BMIPP-201TI mismatch was found only for fibrosis <20%.
CONCLUSION: 123I-BMIPP gave specific information about metabolic changes that occurred in ischemic myocardium without severe fibrotic changes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688114

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Synthesis and evaluation of 15-(4-(2-[¹⁸F]Fluoroethoxy)phenyl)pentadecanoic acid: a potential PET tracer for studying myocardial fatty acid metabolism.

Authors:  Zhude Tu; Shihong Li; Terry L Sharp; Pilar Herrero; Carmen S Dence; Robert J Gropler; Robert H Mach
Journal:  Bioconjug Chem       Date:  2010-11-11       Impact factor: 4.774

Review 2.  Future directions of myocardial fatty acid imaging.

Authors:  Christopher J Pastore; John W Babich; James E Udelson
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

Review 3.  The Japanese experience with metabolic imaging in the clinical setting.

Authors:  Nagara Tamaki; Koichi Morita; Yuko Kawai
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

Review 4.  Metabolic imaging using SPECT.

Authors:  Junichi Taki; Ichiro Matsunari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

5.  Clinical utility of myocardial fatty acid imaging in patients with end-stage renal disease.

Authors:  Masato Nishimura; Toshihiko Ono
Journal:  J Nucl Cardiol       Date:  2008-09-16       Impact factor: 5.952

6.  Incremental predictive value of myocardial scintigraphy with 123I-BMIPP in patients with acute myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Mamoru Nanasato; Haruo Hirayama; Akitada Ando; Satoshi Isobe; Makoto Nonokawa; Yoshimi Kinoshita; Ichiro Nanbu; Mitsuhiro Yokota; Toyoaki Murohara
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-01       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.